Elevated Risks for Depression and Anxiety Following Diagnosis of Multiple Myeloma
- 13 October 2026
- journal article
- Published by Wiley in European Journal of Haematology
Abstract
Background: Patients with multiple myeloma (MM) may be particularly vulnerable to depression and anxiety following diagnosis due to high disease burden, treatment‐related side effects, and the incurable nature of the disease. Methods: In this nationwide population‐based cohort study, we used Danish population‐based registries to investigate the risk of depression and anxiety in patients with MM (symptomatic MM and smoldering MM) compared with age‐ and sex‐matched individuals from the general population. Results: A total of 3861 patients with MM and 19 305 matched comparators were included (median age 73 years; 59% male). During follow‐up, depression and/or anxiety occurred in 315 MM patients (8.2%) and 660 comparators (3.4%). MM was associated with a substantially increased risk of depression and/or anxiety (adjusted HR 2.56, 95% CI 2.23–2.94). The association was strongest among patients with symptomatic MM (adjusted HR 2.63, 95% CI 2.21–3.12) but remained elevated among patients with smoldering MM (adjusted HR 1.44, 95% CI 1.10–1.87). The association was strongest during the first year following diagnosis and attenuated over time. Conclusion: These findings demonstrate an elevated risk of depression and/or anxiety among patients with both symptomatic and smoldering MM and highlight the need for increased awareness of psychological morbidity, particularly during the first year after diagnosis.Keywords
Funding Information
- Kræftens Bekæmpelse (R150‐A10023)
This publication has 37 references indexed in Scilit:
- The Association Between Multiple Myeloma and Neuropsychiatric Manifestations: A Narrative ReviewPsycho-Oncology, 2026
- Quality of cancer-related data from the Danish National patient registry (1994–2025) and the Danish cancer registry (2004–2025): a systematic reviewEuropean Journal of Epidemiology, 2026
- The mechanism of cancer-depression comorbidityNeuroscience, 2024
- Anxiety and depression in adult cancer patients: ESMO Clinical Practice GuidelineESMO Open, 2023
- Positive predictive values of hematological procedure codes in the Danish National Patient Registry—A population‐based validation studyPharmacoepidemiology and Drug Safety, 2022
- Mental health among patients with non‐Hodgkin lymphoma: A Danish nationwide study of psychotropic drug use in 8750 patients and 43 750 matched comparatorsAmerican Journal of Hematology, 2022
- Methodical considerations on adjusting for Charlson Comorbidity Index in epidemiological studiesEuropean Journal of Epidemiology, 2021
- Trend of depression and its association with sociodemographic and clinical factors among multiple myeloma hospitalizations: A Portuguese nationwide study from 2000 to 2015Psycho-Oncology, 2020
- Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patientsCancer Medicine, 2020
- Distress and quality of life in patient and caregiver dyads facing stem cell transplant: identifying overlap and unique contributionsSupportive Care in Cancer, 2018